Is it safe to use Zofran (ondansetron) while breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron (Zofran) and Breastfeeding

Ondansetron is safe and compatible with breastfeeding and can be used when clinically indicated for nausea and vomiting without requiring any waiting period or pumping-and-dumping. 1, 2

Guideline-Based Recommendations

The Association of Anaesthetists 2020 guidelines explicitly recommend ondansetron as a safe anti-emetic option for breastfeeding women, based on expert consensus from this major specialty society. 1, 2 While there are no published studies on transfer into human milk (only animal data exists), the clinical recommendation supports its use without restrictions. 1

No interruption of breastfeeding is necessary after ondansetron administration. 2 Women can continue nursing immediately after taking the medication without any delay or need to discard breast milk. 2

FDA Labeling Information

The FDA label acknowledges uncertainty, stating "it is not known whether ondansetron is present in human milk" and notes that ondansetron is present in rat milk. 3 The label recommends considering "the developmental and health benefits of breastfeeding along with the mother's clinical need for ondansetron tablets and any potential adverse effects on the breastfed infant." 3 However, this cautious regulatory language should be interpreted in the context of the more definitive guideline recommendations from specialty societies. 1, 2

Clinical Approach

  • Use ondansetron when clinically indicated for nausea and vomiting in breastfeeding women without hesitation. 1, 2
  • Reassure mothers that current anesthesia guidelines support its safety profile during lactation. 1, 2
  • No special precautions such as timing feeds around doses or discarding milk are required. 2

Important Context

The lack of human milk transfer data does not equate to risk—many medications used safely during breastfeeding have limited pharmacokinetic data. 4 The guideline recommendation reflects the clinical consensus that ondansetron's properties (likely minimal transfer if any, poor oral bioavailability if transferred) make it compatible with breastfeeding. 1, 2

Common pitfall to avoid: Do not unnecessarily discourage breastfeeding or recommend pumping-and-dumping based solely on the absence of human milk data when authoritative guidelines explicitly support its use. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ondansetron Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.